| Rubicon Research Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 544578 |
NSE Symbol : RUBICON |
P/E(TTM) : 107.26 |
|
ISIN Demat : INE506V01022 |
Div & Yield% : 0.10 |
EPS(TTM) : 14.22 |
|
Book Value(₹) : 81.76 |
Market Cap(₹Cr) : 25,248.58 |
Face Value(₹) : 1.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,306.08 | 1,073.84 | 630.51 | 393.52 | 400.04 |
| Other Income | 10.83 | 19.68 | 26.43 | 25.48 | 17.38 |
| Stock Adjustments | 33.36 | 10.94 | 10.70 | 49.24 | -8.75 |
| Total Income | 1,350.27 | 1,104.46 | 667.64 | 468.24 | 408.67 |
| EXPENDITURE : | |||||
| Raw Materials | 381.08 | 319.22 | 225.15 | 149.40 | 94.55 |
| Power and Fuel Cost | 24.25 | 20.01 | 18.31 | 15.71 | 10.19 |
| Other Manufacturing Expenses | 132.88 | 89.09 | 60.55 | 50.11 | 40.30 |
| Selling and Administration Expenses | 307.11 | 250.73 | 171.79 | 104.28 | 83.51 |
| Miscellaneous Expenses | 19.20 | 8.10 | 7.58 | 7.66 | 63.39 |
| Employee Benefit Expenses | 164.27 | 127.74 | 84.71 | 97.12 | 59.29 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 321.49 | 289.58 | 99.56 | 43.97 | 57.45 |
| Interest | 30.96 | 34.29 | 30.53 | 18.96 | 9.02 |
| Gross Profit | 290.53 | 255.29 | 69.03 | 25.01 | 48.43 |
| Depreciation | 37.75 | 32.01 | 34.95 | 36.06 | 31.51 |
| Profit Before Tax | 252.78 | 223.28 | 34.08 | -11.05 | 16.92 |
| Current Tax | 68.43 | 57.92 | 11.24 | 8.32 | 2.78 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -3.81 | -2.18 | -1.51 | -2.48 | -2.54 |
| Reported Net Profit | 188.17 | 167.54 | 24.35 | -16.89 | 16.68 |
| Extraordinary Items | -0.73 | -0.85 | 0.01 | 0.03 | 0.36 |
| Adjusted Net Profit | 188.90 | 168.39 | 24.34 | -16.92 | 16.32 |
| Adjustment below Net Profit | 6.23 | 1.96 | 0.00 | 0.00 | 0.01 |
| Profit/Loss Balance carried down | 368.28 | 199.09 | 174.99 | 42.49 | 146.18 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.31 | 0.30 | 0.25 | 0.25 | 0.51 |
| P & L Balance carried down | 562.36 | 368.28 | 199.09 | 25.34 | 162.36 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 150.00 | 2.00 | 2.00 | 5.00 | 0.00 |
| Dividend Per Share(Rs) | 1.50 | 0.02 | 0.02 | 0.50 | 0.00 |
| Earnings Per Share-Unit Curr | 11.40 | 10.87 | 1.60 | -33.31 | 32.91 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 81.97 | 43.33 | 31.29 | 564.84 | 845.39 |
| Book Value(Adj)-Unit Curr | 81.97 | - | - | - | - |
